EVLV Should I Buy

TD Cowen reinstated coverage of Evolv with a Buy rating and $10 price target. Under new management, the company's statements have been completed and its regulatory overhangs have "gradually diminished." the analyst tells investors in a research note. The firm says Evolv reported "healthy" Q2 results and raised its fiscal 2025 revenue outlook as it sees momentum across major verticals.